Investor Releases

Date Title View
07 December, 2009 ICON Announces Details of New Translational Medicine Unit in Manchester
04 December, 2009 ICON Receives Warning Letter Relating to Two Studies
02 November, 2009 ICON Selected by Lilly to Oversee its Clinical Data Management in Japan
21 October, 2009 ICON Reports 14% Increase in EPS, and Raises Earnings Guidance for 2009
23 July, 2009 ICON plc: Results of Annual General Meeting
22 July, 2009 ICON Reports 22% Increase in EPS and Strong Cash Flows (NASDAQ:ICLR) (ISIN:IE0005711209)
09 July, 2009 Letter to Shareholders of ICON plc
09 July, 2009 ICON Acquires Veeda Laboratories Limited
26 June, 2009 ICON Central Laboratories in Singapore Moves to New Facility to Meet Growing Demand
18 June, 2009 New Safety Regulations Drive Greater Need for Resources and Expertise at Every Stage of Clinical Development
16 June, 2009 ICON Announces Collaboration to Develop New Translational Medicine Unit at Purpose-built Hospital Facility in Manchester
09 June, 2009 ICON Selected to Manage Lilly Clinical Trial Site Set Up and Monitoring in Europe
28 April, 2009 ICON Reports 9% Increase in Revenue, 25% Increase in EPS and Acquisition of a U.S. Phase I Facility
28 April, 2009 ICON Acquires Assets of Qualia Clinical Services, Inc.
24 April, 2009 ICON Announces Appointment of Dr. Anthony J. Murphy to the Board of Directors
07 April, 2009 ICON Completes CAP Accreditation of its Central Laboratories in Singapore and India
16 March, 2009 ICON and MedAvante Sign Alliance Agreement
23 February, 2009 ICON reports Full-Year 2008 revenue growth of 37% operating income growth of 44% and EPS growth of 38% (NASDAQ:ICLR) (ISIN:IE0005711209)
26 January, 2009 ICON Delivers New Electronic Solution to Expedite Clinical Trial Adjudication
19 January, 2009 ICON Recognised as Research Company of the Year at the PharmaTimes Awards
Displaying 261 - 280 of 385


Search Investor